Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials

Initial APL severity leads to a significant proportion of patients non-registered within clinical trials, which may underestimate the real early mortality, which remained nonetheless less than 10% in this study.